financetom
Business
financetom
/
Business
/
T-mobile Us Insider Sold Shares Worth $2,162,640, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
T-mobile Us Insider Sold Shares Worth $2,162,640, According to a Recent SEC Filing
Jun 12, 2024 2:32 PM

05:06 PM EDT, 06/12/2024 (MT Newswires) -- Raul Marcelo Claure, Director, on June 10, 2024, sold 12,000 shares in T-mobile Us ( TMUS ) for $2,162,640. Following the Form 4 filing with the SEC, Claure has control over a total of 3,796,300 shares of the company, with 1,845,922 shares held directly and 1,950,378 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1283699/000128369924000082/xslF345X03/wk-form4_1718226242.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Amazon Says AWS CEO Adam Selipsky to Step Down, Matt Garman to Take Over
Update: Amazon Says AWS CEO Adam Selipsky to Step Down, Matt Garman to Take Over
May 14, 2024
10:07 AM EDT, 05/14/2024 (MT Newswires) -- (Updates to add details in the second and third paragraphs.) Amazon.com ( AMZN ) announced Tuesday that Adam Selipsky will step down as chief executive of AWS and that Matt Garman will replace him, effective June 3. Selipsky spent 15 years in AWS, while Garman has been with AWS for 18 years, most...
Apellis Pharmaceuticals Enters Into Senior Secured Credit Facility With Sixth Street
Apellis Pharmaceuticals Enters Into Senior Secured Credit Facility With Sixth Street
May 14, 2024
10:02 AM EDT, 05/14/2024 (MT Newswires) -- Apellis Pharmaceuticals ( APLS ) said Tuesday it entered into a senior secured credit facility of up to $475 million with Sixth Street, with roughly $375 million financed at completion. Under the terms, Apellis can draw a further $100 million before September 2025, the biopharmaceutical company added. The new credit facility will mature...
Kirby Insider Sold Shares Worth $285,828, According to a Recent SEC Filing
Kirby Insider Sold Shares Worth $285,828, According to a Recent SEC Filing
May 14, 2024
10:01 AM EDT, 05/14/2024 (MT Newswires) -- Dorman Lynn Strahan, President, Kirby Engine Systems, on May 10, 2024, sold 2,470 shares in Kirby (KEX) for $285,828. Following the Form 4 filing with the SEC, Strahan has control over a total of 18,584 shares of the company, with 18,584 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/56047/000095017024059171/xslF345X03/ownership.xml Price: 114.25, Change: -0.16, Percent Change:...
FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
May 14, 2024
Tuesday, Dynavax Technologies Corporation ( DVAX )  provided a regulatory update for its supplemental Biologics License Application (sBLA) to include a four-dose HEPLISAV-B vaccine regimen for adults on hemodialysis.  The FDA has issued a Complete Response Letter stating that the application did not provide sufficient data to fully evaluate the effectiveness or safety of a four-dose regimen of HEPLISAV-B.  The CRL has...
Copyright 2023-2026 - www.financetom.com All Rights Reserved